International trade · 25/06/2004Updated: 10/17/2026 · 1 min read

U.S. International Trade Commission Launches Investigation into Injectable Implant Compositions

The U.S. International Trade Commission has begun an investigation into a complaint filed by Inamed Corporation, alleging that certain injectable implant compositions infringe on U.S. Patent No. 4,803,075 and pose a threat to the U.S. industry, prompting a request for permanent exclusion orders and cease-and-desist actions.